See more : aifinyo AG (EBE.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Theraclion SA (ALTHE.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Theraclion SA, a leading company in the Medical – Devices industry within the Healthcare sector.
- PT Jaya Konstruksi Manggala Pratama Tbk (JKON.JK) Income Statement Analysis – Financial Results
- Delta Electronics, Inc. (2308.TW) Income Statement Analysis – Financial Results
- Les Constructeurs du Bois S.A. (MLLCB.PA) Income Statement Analysis – Financial Results
- PT Wilmar Cahaya Indonesia Tbk. (CEKA.JK) Income Statement Analysis – Financial Results
- Metro Brands Limited (METROBRAND.NS) Income Statement Analysis – Financial Results
Theraclion SA (ALTHE.PA)
About Theraclion SA
Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient's skin and optimizes the image quality. The company was founded in 2004 and is based in Malakoff, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.82M | 1.24M | 1.48M | 744.00K | 2.78M | 1.94M | 2.82M | 1.98M | 1.60M | 819.68K | 76.50K | 3.00 | 937.42K | 212.96K |
| Cost of Revenue | 2.90M | 4.29M | 6.02M | 4.55M | 6.80M | 4.47M | 5.23M | 4.68M | 4.82M | 2.79M | 2.19M | 1.78M | 1.11M | 995.70K |
| Gross Profit | -1.08M | -3.05M | -4.54M | -3.81M | -4.02M | -2.53M | -2.40M | -2.70M | -3.22M | -1.97M | -2.12M | -1.78M | -170.42K | -782.74K |
| Gross Profit Ratio | -59.29% | -246.91% | -306.55% | -511.69% | -144.29% | -130.32% | -85.06% | -136.91% | -201.44% | -239.97% | -2,769.38% | -59,460,900.00% | -18.18% | -367.55% |
| Research & Development | 0.00 | 4.30M | 3.82M | 2.10M | 3.60M | 3.60M | 3.80M | 3.20M | 2.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 3.10M | 224.00K | 479.00K | 590.00K | 2.56M | 2.89M | 4.30M | 3.52M | 2.48M | 2.05M | 0.00 | 0.00 | 0.00 |
| Other Expenses | -1.08M | 0.00 | 27.00K | 0.00 | 86.00K | 1.00K | -167.12K | 37.21K | -150.95K | 0.00 | 183.09K | 1.86M | 1.91M | 1.50M |
| Operating Expenses | -1.08M | 2.87M | 197.00K | 479.00K | 504.00K | 4.54M | 4.74M | 4.81M | 3.86M | 3.02M | 2.43M | 1.86M | 1.91M | 1.50M |
| Cost & Expenses | 4.98M | 7.16M | 6.22M | 5.03M | 7.31M | 9.00M | 9.96M | 9.49M | 8.68M | 5.81M | 4.62M | 3.65M | 3.02M | 2.50M |
| Interest Income | 30.79K | 44.06K | 74.06K | 261.34K | 231.03K | 259.55K | 232.34K | 229.52K | 156.98K | 170.97K | 1.57K | 3.42K | 10.95K | 155.00 |
| Interest Expense | 31.46K | 44.06K | 136.00K | 330.00K | 221.00K | 274.00K | 234.91K | 240.46K | 163.75K | 188.28K | 126.39K | 32.18K | 2.79K | 26.27K |
| Depreciation & Amortization | 205.48K | 109.32K | 90.71K | 436.02K | 420.45K | 554.74K | 362.62K | 351.74K | 375.36K | 303.62K | 301.12K | 438.69K | 349.81K | 308.02K |
| EBITDA | -4.49M | -5.74M | -5.33M | -4.15M | -4.48M | -6.62M | -6.74M | -7.17M | -6.73M | -4.66M | -4.06M | -3.20M | -1.73M | -1.98M |
| EBITDA Ratio | -246.25% | -498.84% | -297.35% | -557.74% | -160.91% | -341.53% | -238.48% | -363.00% | -429.78% | -567.97% | -5,549.87% | -106,915,900.00% | -184.96% | -928.81% |
| Operating Income | -3.15M | -6.31M | -4.74M | -4.29M | -4.52M | -6.98M | -7.10M | -7.49M | -7.24M | -4.96M | -4.55M | -3.65M | -2.08M | -2.29M |
| Operating Income Ratio | -173.09% | -510.54% | -319.85% | -576.08% | -162.39% | -359.79% | -251.32% | -379.09% | -453.28% | -605.01% | -5,943.50% | -121,539,033.33% | -222.28% | -1,073.45% |
| Total Other Income/Expenses | -1.57M | 341.58K | -108.08K | -341.00K | -540.00K | -345.92K | -273.91K | -260.49K | 1.82K | -201.30K | 58.26K | -28.76K | 2.78K | -26.11K |
| Income Before Tax | -4.72M | -5.97M | -4.64M | -4.63M | -5.06M | -7.32M | -7.37M | -7.75M | -7.24M | -5.16M | -4.49M | -3.67M | -2.08M | -2.31M |
| Income Before Tax Ratio | -259.25% | -482.89% | -313.50% | -621.91% | -181.79% | -377.63% | -261.02% | -392.28% | -453.17% | -629.57% | -5,867.35% | -122,497,700.00% | -221.98% | -1,085.71% |
| Income Tax Expense | -1.05M | 1.00M | -883.00K | -722.00K | -1.27M | 1.18M | 1.15M | 1.21M | 826.38K | 526.34K | -377.53K | -602.18K | -405.83K | -397.13K |
| Net Income | -3.68M | -4.96M | -3.76M | -3.91M | -3.79M | -6.14M | -6.22M | -6.54M | -6.41M | -4.63M | -4.11M | -3.07M | -1.68M | -1.91M |
| Net Income Ratio | -201.68% | -401.83% | -253.88% | -524.87% | -136.21% | -316.84% | -220.38% | -330.93% | -401.43% | -565.35% | -5,373.82% | -102,425,200.00% | -178.69% | -899.23% |
| EPS | -0.08 | -0.17 | -0.17 | -0.24 | -0.25 | -0.73 | -0.83 | -1.01 | -1.58 | -1.32 | -1.44 | -1.03 | -0.56 | -0.64 |
| EPS Diluted | -0.08 | -0.17 | -0.17 | -0.24 | -0.25 | -0.73 | -0.83 | -1.01 | -1.58 | -1.32 | -1.37 | -1.03 | -0.56 | -0.64 |
| Weighted Avg Shares Out | 45.73M | 29.39M | 22.77M | 16.18M | 15.25M | 8.44M | 7.47M | 6.44M | 4.06M | 3.50M | 2.85M | 2.99M | 2.99M | 2.99M |
| Weighted Avg Shares Out (Dil) | 48.28M | 29.39M | 22.77M | 16.18M | 15.25M | 8.44M | 7.47M | 6.44M | 4.06M | 3.50M | 2.99M | 2.99M | 2.99M | 2.99M |
Source: https://incomestatements.info
Category: Stock Reports